- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05762978
Evaluation of Negative Inspiratory Flow in Children With Acute Asthma
Negative Inspiratory Flow (NIF) in Children Age 4-8 Years During Acute Asthma to Evaluate the Use of a Dry Powder Inhaler: A Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Inhaler devices are the major method for delivery of asthma medication, but their effectiveness can be compromised if the patient uses the inhaler device incorrectly. The magnitude of this problem has been well documented; in several studies less than half of the patients used their inhaler correctly. Inhaler devices are used to deliver a variety of inhaled medications, including beta-agonists, anticholinergic, and glucocorticoids. Two main types of inhaler devices are available, the pressurized metered dose inhaler (pMDI) and the dry powder inhaler (DPI).
A dry powder inhaler (DPI) is a breath-actuated device containing micronized drug particles with a mass median aerodynamic diameter (MMAD) of less than 5 µm that are usually aggregated with carrier particles (such as lactose or glucose) of greater diameter. Drug is delivered to the airways by the inhalation of air over a punctured drug-containing capsule or blister.
In this study investigators will evaluate the use of DPI use in children during an acute asthma exacerbation. The investigators hypothesize the use of DPI in children ages 4-8 during an asthma exacerbation has limited benefit, as children are unable to generate the needed NIF. The investigators will study children who were hospitalized for an acute asthma exacerbation. Additionally, the investigators will evaluate the participant as an outpatient in the pulmonary clinic / office when the participant is without an asthma exacerbation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Mineola, New York, United States, 11501
- Winthrop University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Hospitalized with asthma
- Age ≥ 4 years and < 8 years
Exclusion Criteria:
- Acute Lung Disease
- Chronic lung disease
- Developmental Delay
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Asthmatic Children
NIF will be measured using an In-Check Dial
|
Patient will have their NIF measured with In-Check Dial
Children will use inhaler per standard of care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
NIF (Negative Inspiratory Flow)
Time Frame: Time of Hospital Admission (Day 1)
|
NIF measures a patient's maximum inspiratory effort after exhaling.
|
Time of Hospital Admission (Day 1)
|
NIF (Negative Inspiratory Flow)
Time Frame: Hospital Discharge (Typically Day 1-2)
|
NIF measures a patient's maximum inspiratory effort after exhaling.
|
Hospital Discharge (Typically Day 1-2)
|
NIF (Negative Inspiratory Flow)
Time Frame: Follow-Up Visits (Week 2 Post-Discharge)
|
NIF measures a patient's maximum inspiratory effort after exhaling.
|
Follow-Up Visits (Week 2 Post-Discharge)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Claudia Halaby, MD, Winthrop University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15035
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Asthma
-
Vanderbilt University Medical CenterNot yet recruitingAsthma in Children | Asthma Attack | Asthma Acute | Acute Asthma Exacerbation | Asthma; StatusUnited States
-
University of California, San FranciscoCompletedAsthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicUnited States
-
SingHealth PolyclinicsNot yet recruitingAsthma | Asthma in Children | Asthma Attack | Asthma Acute | Asthma Chronic
-
Johann Wolfgang Goethe University HospitalCompleted
-
Universita di VeronaCompleted
-
Parc de Salut MarActive, not recruitingAsthma in Children | Persistent Asthma | Asthma ExacerbationSpain
-
Forest LaboratoriesCompleted
-
Brunel UniversityKarolinska InstitutetUnknown
-
Johann Wolfgang Goethe University HospitalCompletedExercise-induced AsthmaGermany
Clinical Trials on In-Check Dial
-
Universitair Ziekenhuis BrusselNot yet recruitingAsthma | COPD
-
University of Alabama at BirminghamWithdrawnChronic Obstructive Pulmonary DiseaseUnited States
-
Universitair Ziekenhuis BrusselUnknownCOPD | Severe AsthmaBelgium
-
Virginia Commonwealth UniversityTerminatedHypertensionUnited States
-
Massachusetts General HospitalJuvenile Diabetes Research Foundation; Boston Children's HospitalNot yet recruitingType 1 Diabetes | Diabetes in Children
-
Northwestern UniversityNational Institutes of Health (NIH); Alzheimer's Association; Illinois Department... and other collaboratorsCompletedFrontotemporal Dementia | Primary Progressive AphasiaUnited States
-
Babes-Bolyai UniversityNorwegian University of Science and Technology; CheckWare ASCompleted
-
University of RochesterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Active, not recruitingChronic Kidney Diseases | End Stage Renal DiseaseUnited States
-
Butler HospitalNational Institute of Mental Health (NIMH); Brown UniversityEnrolling by invitationSchizophrenia | Bipolar Disorder | Major DepressionUnited States
-
Centers for Disease Control and PreventionNorthwestern University; Emory University; Public Health SolutionsCompleted